/PRNewswire/ -- Defying the national trend of only 1.5 percent of eligible hospitals attesting in 2014, St. Elizabeth Hospital in Enumclaw, Wash. achieved Meaningful Use Stage 2 using MEDITECH technology. St. Elizabeth accomplished Stage 2 with information technology (IT) support from Engage, a division of Inland Northwest Health Services (INHS).
Siemens and Stand Up To Cancer® spread message of hope, highlight promise of research through national campaign Join the campaign at facebook.com/TheBatonPass
The Academy of Nutrition and Dietetics has created a unique web application platform with tools to help registered dietitian nutritionists provide the highest-quality care for patients and clients, track outcomes of their interventions, conduct research in important areas of nutrition science and contribute to a national quality registry.
Meridian Bioscience Inc. has entered into a technology and commercial license agreement with the UT Research Foundation for the development of the technology that could result in low cost, point-of-care disease detection using a portable device. Meridian Bioscience is a life science company that manufactures, markets and distributes a range of diagnostic test kits and other technologies.
23andMe and Pfizer Inc. announce a new research collaboration to study Inflammatory Bowel Disease (IBD) in a nationwide initiative designed to recruit and genotype individuals who have Crohn’s disease or ulcerative colitis.
Odessa Memorial Healthcare Center in Odessa, Wash. is the first Critical Access Hospital (CAH) to successfully attest to Stage 2 of the Meaningful Use electronic health record (EHR) incentive program using MEDITECH Information Technology, Inc. administered by Engage, a division of Inland Northwest Health Services (INHS).
TAXIS Pharmaceuticals, Inc. today announced the acquisition of a group of novel antimicrobial drug candidates from Biota Pharmaceuticals Inc.
SAGE Labs Inc., a leading provider of products, services and technologies in the field of genome engineering, announced today that they have licensed CRISPR/Cas9 technology from the Broad Institute. The license enables SAGE Labs to use the CRISPR/Cas9 system to engineer cell and animal models for their clients as well as distribute validated CRISPR reagents. This is the second license obtained by SAGE Labs around CRISPR/Cas9 technology; SAGE also obtained a license from Caribou Biosciences in September 2013.
PrimerDesign has today announced the launch of the World's most affordable qPCR Machine. The new instrument shatters typical market pricing coming in at $6500 for a high spec 16-well instrument.
CHICAGO, I.L. – July 29, 2014 - OHAUS Corporation, a leading manufacturer and marketer of high quality balances and scales, is set to announce the launch of its new Adventurer line of analytical and precision balances at the American Association for Clinical Chemistry (AACC) Annual Meeting in Chicago July 29-31. The new Adventurers, which will be available for purchase beginning in late September 2014, will be on display in OHAUS Booth #4473 for the duration of the AACC meeting.
CHICAGO, I.L. – July 29, 2014 - OHAUS Corporation, a leading manufacturer and marketer of high quality balances and scales, is set to announce the launch of its new Adventurer line of analytical and precision balances at the American Association for Clinical Chemistry (AACC) Annual Meeting in Chicago July 29-31. The new Adventurers, which will be available for purchase beginning in late September 2014, will be on display in OHAUS Booth #4473 for the duration of the AACC meeting.
Anteo Diagnostics, the inventor and develop of the Mix&Go molecular velcro surface chemistry is please to announce the launch of the Mix&Go based AMG™ Coupling Kit at the 2014 AACC Annual Meeting & Clinical Expo in Chicago.
Compact Dry is a self-contained device containing a membrane matrix saturated with a culture medium and a gelling agent, and then dried. A diluted food sample (1mL) is added to the center of the device, which diffuses automatically and evenly throughout the plate. The device is then incubated, after which a technician counts the colonies.
The Vision MINI Xi smart camera is the world's smallest machine vision system available with embedded Ethernet connectivity. Housed in our patented mini design and featuring built in lens and LED lighting, our award-winning compact smart camera is now available for flexible implementation of machine vision inspection (from decoding to color matching to OCR and more) into industrial environments. The Vision MINI Xi has corner-exit cables with both serial and Ethernet options to meet any connectivity requirement in space-constrained applications, and also packs 24 V interface, optically isolated I/O, and autofocus into its tiny form factor for powerful machine vision tasks with a small footprint.
The Precision Fluidics Division of Parker Hannifin Corporation, the global leader in motion and control technologies, announces the release of its newest Diaphragm Isolation liquid Valve. This 6.4 mm diaphragm isolation valve improves performance of Clinical Diagnostic and Analytical Chemistry systems requiring precision fluid and delivers liquid dispense performance in a very small package. At just 6.4 mm wide it can be easily mounted over microplates improving performance and saving space. When mounted on a manifold the R6’s ultra-small footprint enables smaller and more efficient fluidic circuits by taking less space and shortening fluid channels. The R6 provides solutions to today’s demanding analytical, clinical and agent detection applications.
The new A2 (A-squared) Multiplex IA glass slide offers the user an open platform from which to prepare quantitative multiplex immunoassays of their choice
New APN--W from Iwaki America
Focus Diagnostics received expedited FDA 510(k) clearance and CLIA moderate complexity categorization for its new Simplexa HSV 1 & 2 Direct molecular test on the Integrated Cycler. The test, which is now available for purchase in the United States, is the first molecular test to be cleared by the FDA for the qualitative detection and differentiation of herpes simplex virus 1 (HSV-1) and herpes simplex virus 2 (HSV-2) in cerebrospinal fluid (CSF) from patients suspected of HSV central nervous system (CNS) infection, including encephalitis. The test uses a proprietary process that eliminates nucleic acid extraction, so clinicians can expect results within about an hour after providing a specimen for testing.
Cerilliant® brand has introduced six new certified Snap-N-Spike® solutions of designer psychedelics in the NBOMe class of phenethylamines.
Abbott is developing diagnostic solutions for today and tomorrow, which it will showcase during the American Association for Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Expo, July 27 through July 31, 2014, in Chicago.
Atomo Diagnostics is introducing the world’s first integrated rapid blood test device to the USA market at the 2014 AACC Annual Meeting & Clinical Lab Expo (July 27-31) following a successful presentation at the 20th International AIDS Conference 2014 in Melbourne (July 20 -25, 2014).
UNIConnect announced the release of its new PrecisionMDx (PMDx) System. Building upon a history of software engineering and support for research, development and delivery in the "omic" sciences, PMDx represents dramatic innovation driven by experience gained from the interplay of client and vendor in the realm of molecular diagnostic test development.
Rees Scientific (www.reesscientific.com) a leading provider of Automated Temperature and Environmental Monitoring Systems is introducing Presidio On The Go.
Spark Holland B.V. is pleased to announce the publication of US patent no. US 8586382 B2.
H618 HbA1c Meter
Dry System, Maintenance free
In Q3 of 2013, Randox announced that the Food and Drug Administration has approved the company’s Acusera Immunoassay Speciality 1 quality control for use in US laboratories.
Orchard Software is proud to introduce a new enterprise-class LIS—Orchard® Sequoia™—built on completely new technology to aid laboratories in their positive impact on healthcare informatics, diagnostics, and patient outcomes.
Angel Eye Camera Systems, a company established in 2013 with support from the University of Arkansas for Medical Sciences (UAMS) BioVentures, recently completed the installation of 79 camera systems in the neonatal intensive care units (NICU) at Texas Health Presbyterian Hospital Dallas, Texas Health Presbyterian Hospital Plano and at Texas Health Harris Methodist Hospital Fort Worth. Complete with audio, parents can see and talk to their baby anytime, day or night from their mobile phone or computer.
Multisorb will be exhibiting at 2014 AACC where technical staff will be available to discuss its sorbent products and programs, including its Calculation Through Operations Program. The program can help save 6-12 months of development time.
All parameters available K, Na, Cl, iCa, nCa, TCa, pH, Li, Mg, TCO2, AG
UTAK Laboratories, Inc., dedicated to meeting the quality control needs of laboratories worldwide, proudly announced today the release of the first Steroid Control manufactured with UTAK’s proprietary SMx™ Specialty Matrix. UTAK’s 3rd party Steroid Control product is a revolutionary advancement over current market offerings.
Chicago, Illinois, May 16, 2014 – Hi-Tech Holdings, LLC (“Hi-Tech” or “Hi-Tech Manufacturing”), a portfolio company of May River Capital, LLC (“May River”), announced it has acquired a majority interest in GCM Medical and OEM, Inc. and Global Contract Manufacturing (HK) Limited (together, “GCM” or the “Company”). Headquartered in Union City, California, with a second facility in Dongguan, China, GCM is a preferred supplier of contract manufacturing services to leading OEMs in the medical, industrial, transportation, and aerospace sectors. Based in Schiller Park, Illinois, Hi-Tech is a world class manufacturer of low-to-medium volume, mission-critical precision machined components and assemblies.
The FDA has cleared Randox's Immunoassay Premium Plus quality control for use in US laboratories. A multi-analyte control, it combines 52 analytes including tumour markers, hormones, therapeutic drugs and Vitamin D.
ZeptoMetrix™ Corporation (ZMC), launches a new FDA Class 1 exempt, in vitro diagnostic, CE marked, unassayed external run control intended for use with multiplexed, respiratory molecular assays. The NATtrol™ RP Multimarker Controls - MDZ001 has been specifically designed for routine and repetitive laboratory use to monitor daily test variation, lot-to-lot test kit performance, individual operator variation and may also provide assistance in identifying increases in random or systematic error(s).
Leading laboratory quality management systems provider SoftTech Health LLC will be exhibiting the latest developments in Quality Management and Document Control solutions, at the 2014 Annual AACC Meeting and Clinical Lab Expo. Personalized demonstrations of these advanced new features and updates include the ability to create on the fly ‘Ad-Hoc’ document approval routing, allowing for greater flexibility and unlimited workflow potential; the capability to unlock and expand delegation of administration abilities, providing greater control and security; and the flexibility to combine and integrate independent modules for the entire suite of products.
EKF Diagnostics, the global diagnostics company, will be highlighting its expanding product portfolio on its subsidiary Stanbio Laboratory’s booth #1933 at the AACC Clinical Lab Expo in Chicago, USA, July 29-31. In addition to demonstrating success of current products, including Stanbio’s ß-HB assay technology and EKF Molecular’s Pointman technology, new products will be introduced at AACC. These latest introductions are a result of EKF’s recent acquisition of Separation Technology Inc. (STI) and DiaSpect Medical.
COLA, the largest private accreditor of medical laboratories serving more than 8,000 across the U.S., successfully concluded its 2014 Leadership Summit in April. More than 30 thought leaders in health care, including physicians, regulators, public health experts, medical laboratory scientists, manufacturers, nurse practitioners and more gathered in San Francisco to discuss the future of laboratory medicine in the context of the Affordable Care Act (ACA). The group explored the implications of the dynamics of ACA and changing payment policies on quality and learning in laboratory medicine.
The nation’s healthcare system -- and with it, the laboratory community – is undergoing a period of tremendous change as The Affordable Care Act begins implementation and new healthcare delivery models such as The Patient-Centered Medical Home (PCMH) and Accountable Care Organizations (ACOs) proliferate. With more than 70 percent of medical decisions based on lab data, laboratories are emerging as vital partners of these new healthcare teams. Labs are uniquely qualified to use the patient data they capture to provide feedback to allied health professionals that can increase efficiency and contain health-care costs while improving patient care.
COLA Inc., based in Columbia, MD, an independent, nonprofit laboratory CLIA-accreditation organization, accrediting more than 7,000 clinical diagnostic labs on July, 2013, launched a new education subsidiary, COLA Resources Inc. (CRI®), whose mission is to “Provide educational & consultative services aimed at improving laboratory medicine and patient care.”
Diazyme Laboratories today announced that the U.S. Food and Drug Administration (FDA) has granted 510(K) clearance to market its Vitamin D assay for Clinical Chemistry Analyzers. In line with the rapid increasing clinical demands for testing of this important biomarker, Diazyme’s new Vitamin D assay, utilizing its femtoquantTM technology (a sensitive homogenous enzyme-immunoassay platform), provides the first fully automated Vitamin D test for use on general clinical chemistry analyzers. Diazyme’s Vitamin D assay measures total 25-hydroxy Vitamin D (sum of 25-(OH)D3 + 25-(OH)D2 ) levels.
Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information and services, today announced that its Focus Diagnostics products business has received expedited FDA 510(k) clearance and CLIA moderate complexity categorization for its new Simplexa™ HSV 1 & 2 Direct molecular test on the 3M Integrated Cycler. The test, which is now available for purchase in the United States, is the first molecular test to be cleared by the FDA for the qualitative detection and differentiation of herpes simplex virus 1 (HSV-1) and herpes simplex virus 2 (HSV-2) in cerebrospinal fluid (CSF) from patients suspected of HSV central nervous system (CNS) infection, including encephalitis. The test uses a proprietary process that eliminates nucleic acid extraction, so clinicians can expect results within about an hour after providing a specimen for testing.
In Q3 of 2013, Randox announced that the Food and Drug Administration has approved the company’s Acusera Immunoassay Speciality 1 quality control for use in US laboratories.
Randox Laboratories has further expanded its market presence in the United States, having been awarded a major supplier agreement with Novation, the leading health care supply chain expertise, analytics and contracting company.
Spark Holland B.V. is pleased to announce the publication of US patent no. US 8586382 B2 which relates to a method and an apparatus for desorption of a blood sample from a medical test sheet comprising at least one dried blood spot (DBS) for the purpose of biomedical analysis of the blood sample. The patent allows that the new method eliminates the need for first punching out a disc area of the test sheet containing dried blood sample, thus speeding up the procedure considerably and that on-line desorption of dried blood spots is faster and easier and allows for further automation of the process.
UTAK Laboratories, Inc., the leading diagnostics manufacturer solely focused on quality controls, announced today the release of expanded Quality Control Panels for Amphetamines, Benzodiazepines and Barbiturates used in drug screening. “Through analysis of orders for our custom products, we noticed a trend that laboratories are requesting extensive panels of these controls, all in a single bottle, for ease of use with mass spectrometry or clinical chemistry methodologies,” said Jim Plutchak, CEO of UTAK.
OEM and custom development systems / liquid handling system / DNA extraction workstation / ABO Blood grouping system / PCR test processing
Addcare Bio-Tech Co., Ltd. provides advanced liquid handling systems, automated immunoassay workstations and customized systems. We create solutions for a wide range of applications by combining our proprietary liquid handling technology with a variety of platforms and modules, each designed to handle a specific task in the configuration.
Beckman Coulter Diagnostics, a global leader in prostate cancer diagnostics, announces national availability of the Prostate Health Index (phi)*, a simple, non-invasive blood test that is three times more specific in detecting prostate cancer1 than PSA (prostate-specific antigen).
Chemclin provides a wide range of chemiluminescent immunoassays for in-vitro diagnosis, covering infectious diseases, tumor markers, thyroid functions, fertility, diabetes, liver fibrosis and other panels. Most of them are CE certified and all of them are designed for both the semi-automated (Chemclin®100) and fully automated (Chemclin®600) chemiluminescent immunosystems in quantitative and qualitative determinations.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right